Dr. Patrick – Publications

Patrick L. “Gastroesophageal Reflux Disease (GERD): A review of conventional and alternative treatments.” Altern Med Rev 2011;16(2):116-133.

Patrick L. “Thyroid disruption: mechanisms and clinical implications in human health” Altern Med Rev 2009 Dec;14(4):326-46. Review. Erratum in: Altern Med Rev. 2010 Apr;15(1):58.

Renee Dufault, Roseanne Schnoll, Walter J Lukiw, Blaise LeBlanc, Charles Cornett, Lyn Patrick, David Wallinga, Steven G Gilbert, Raquel Crider “Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children” Behav Brain Funct. 2009; 5: 44.

Renee Dufault, Blaise LeBlanc, Roseanne Schnoll, Charles Cornett, Laura Schweitzer, David Wallinga, Jane Hightower, Lyn Patrick, Walter J Lukiw. “Mercury from chlor-alkali plants: measured concentrations in food product sugar” Environ Health. 2009; 8:2.

Patrick L. “Iodine: deficiency and therapeutic considerations.” Altern Med Rev 2008 Jun;13(2):116-27. Review.

Patrick L. “Restless legs syndrome: pathophysiology and the role of iron and folate.
Altern Med Rev
. 2007 Jun;12(2):101-12. Review.

Patrick L. “Lead Toxicity a review of the literature. Part II: The role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity.”  Altern Med Rev 2006;11(2):114-127.

Patrick L. “Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment.”  Altern Med Rev. 2006 Mar;11(1):2-22

Patrick L. “Selenium biochemistry and cancer: a review of the literature.” Altern Med Rev 2004;9(3):239-258.

Patrick L. “Toxic metals and antioxidants: part 2. The role of antioxidants in arsenic and cadmium toxicity.” Altern Med Rev 2003;8(2):106-128.

Patrick L.  “Mercury toxicity and antioxidants: part 1. Role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity.” Altern Med Rev  2002;7(6):456-471.

Patrick L. “Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.” Altern Med Rev 2002;7(4):276-291.

Patrick L. “Eating disorders: a review of the literature with emphasis on medical complications and clinical nutrition.” Altern Med Rev 2002;7(3):184-202.

Patrick L. “Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.”  Altern Med Rev 2001; 6(3):248-71.

Dunn-Merritt, S. Patrick L. Everything You Need to Know About Osteoporosis. The Natural Pharmacist Series. Roseville CA: Prima Pub; 2000.

Dunn-Merritt S, Gilman A, Patrick L. Preventing Osteoporosis with Ipriflavone. The Natural Pharmacist Series. Roseville CA: Prima Pub; 2000.

Patrick L. “Beta-carotene: the controversy continues.” Altern Med Rev 2000; 5(6):530-45.  


Patrick L. “Nutrients and HIV: part  3-N-acetylcysteine, alpha-lipoic acid, L-glutamine, and L-carnitine.” Altern Med Rev 2000; 5(4):290-305

Patrick L. “Nutrients and HIV: part 2-vitamins A and E, zinc, B-vitamins, and magnesium.” Altern Med Rev 2000; 5(1):39-51

Patrick L. “Nutrients and HIV: part 1- beta carotene and selenium.” Altern Med Rev 1999;4(6):403-13.

Patrick L. “Hepatitis C: epidemiology and review of complementary/alternative medicine treatments.” Altern Med Rev 1999;4(4): 220-38.

Patrick L. “The treatment of hepatitis C: emerging evidence of the need for change.” Altern Med Rev 1999; 4(4):219

Patrick L. “Comparative absorption of calcium sources and calcium citrate malate for the prevention of osteoporosis”  Altern Med Rev 1999;4(2):74-85.

Patrick, L.  “The Biochemistry and Pathology of Nicotine Dependence.” Journal of Naturopathic Medicine 1998; 8(2):45-48.